GTR Home > Tests > Search results - C1854335[DISCUI]

Apply filters

Showing tests for all 1131 conditions

Compare labs

Your search term can be found in tests with a total of 1131 conditions. Only 1000 conditions are displayed in this filter box. Please type the name of the condition in the search box in this filter to find the specific condition. You can use the filters below to narrow down your results.
If the name of the condition you typed is not present, please try another query or search using the All GTR tab.

  • Hide states

GTR test search results for C1854335[DISCUI]

C Clinical test, R Research test

Showing 1 to 20 of 21 tests for 1131 conditions in 11 labs

CEpilepsy, nocturnal frontal lobe type 3

Lab: Centogene AG - the Rare Disease Company Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CComprehensive Epilepsy Panel

Lab: Transgenomic New Haven, Connecticut, United States
Total conditions (527)
Total targets (377)

CAutosomal Dominant Nocturnal Frontal Lobe Epilepsy via the CHRNB2 Gene

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region

CepiSEEK® Comprehensive Sequence Analysis for Epilepsy and Seizure Disorders (489 genes)

Lab: Courtagen Diagnostics Laboratory Courtagen Life Sciences Woburn, Massachusetts, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (641)
Total targets (439)

CCHRNB2

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CCRH. Complete sequencing

Lab: Instituto de Medicina Genomica Paterna, Comunidad Valenciana, Spain

CEpilepsy Advanced Sequencing Evaluation

Lab: Athena Diagnostics Inc Marlborough, Massachusetts, United States
Total conditions (143)
Total targets (141)

CNeurology: Sequencing Panel

Lab: Emory Genetics Laboratory Emory University Decatur, Georgia, United States
Total conditions (257)
Total targets (165)

CEpilepsy and Seizure Disorders: Sequencing and Deletion/Duplication Panel

Lab: Emory Genetics Laboratory Emory University Decatur, Georgia, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (168)
Total targets (108)

CNuclear-Mito NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (601)
Total targets (504)

CFocal epilepsy panel

Test targets
Methods
  • E Sequence analysis of select exons
  • C Sequence analysis of the entire coding region
Total conditions (10)
Total targets (9)

CEpilepsy NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (598)
Total targets (343)

CEpilepsy, nocturnal frontal lobe 3

Lab: MedGene Bratislava, Bratislava, Slovakia
Test targets
Methods
  • C Sequence analysis of the entire coding region

CEpilepsy, nocturnal frontal lobe 3

Lab: Praxis fuer Humangenetik Wien Vienna, Wien, Austria
Test targets
Methods
  • C Sequence analysis of the entire coding region

Showing 1 to 20 of 21 tests for 1131 conditions in 11 labs

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.